Are lipid-lowering drugs also antiarrhythmic drugs?
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefitJACC, 2001
- Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patientsJACC, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular ArrhythmiasNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methodsThe American Journal of Cardiology, 1995
- Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?JAMA, 1986